3Pannuti C, Gingrich R, Pfaller MA, et al. Nosocomial Pneumonia in patients having bone marrow transplant: attributa ble mortality and risk factors[J].Cancer, 1992, 69 ( 71 ) : 2653-2662.
4Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group[J]. N Eng J Med, 1999,340 (10) :764-771.
5Boogaerts M, Winston DJ, Bow EJ, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad spectrum antibacterial therapy: a randomized, controlled trial[J].Ann Intern Med, 2001, 735(6):472-422.
6Walsh TJ, Pappas P, Winston DJ. et al. Voriconazole compared with liposomal amphotericin B for empirical antifunga therapy in patients with neutropenia and persistent fever[J]. N Eng J Med, 2002,346(4):225-234.
7Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia[J].N Eng J Med, 2004,35! (14) : 1391-1402.
8Deresinski SC. Stevens DA. Caspofungin. Clin Infect Dis[J]. 2003,36(11):1445-1457.
